Dexamethasone for Inpatients With COVID-19 in a National Cohort

IMPORTANCE: Limited effective therapeutics are available to hospitalized patients with COVID-19. Clinical trials and observational studies have shown varying effects of systemic corticosteroids, including dexamethasone, in hospitalized patients with COVID-19, with limited descriptions of important p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mourad, Ahmad, Thibault, Dylan, Holland, Thomas L., Yang, Siyun, Young, Allison R., Arnold Egloff, Shanna A., Thomas, Laine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111178/
https://www.ncbi.nlm.nih.gov/pubmed/37067800
http://dx.doi.org/10.1001/jamanetworkopen.2023.8516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111178/
https://www.ncbi.nlm.nih.gov/pubmed/37067800
http://dx.doi.org/10.1001/jamanetworkopen.2023.8516

Ejemplares similares